INTRODUCTION
============

Repetitive elements form a great portion of most eukaryotic genomes and large-scale studies of their transcriptional activity are now attracting increasing interest. Many genomic repeats have originated from insertions of transposable elements. Retroelements (REs), which proliferate via RNA intermediates, are known to be the only transpositionally active group of transposable elements in mammals. In vertebrates, REs occupy up to 30--40% of the genome ([@b1]--[@b4]). Being mobile carriers of transcriptional regulatory modules, REs can affect regulation of host genes, in particular those involved in embryo development, thus being probable candidates for playing a role in speciation processes ([@b5]).

It was recently demonstrated that REs can drive the transcription of unique host non-repetitive sequences ([@b6],[@b7]). Many kinds of genomic repeats are known to be transcribed *in vivo* ([@b8],[@b9]). However, a significant portion of such expressed repeats was found within larger transcripts driven from upstream genomic promoters. Conventional and popular methods for transcriptome analysis such as RT--PCR, differential display ([@b10],[@b11]), subtractive hybridization ([@b12]--[@b14]), serial analysis of gene expression ([@b15]) and microarray hybridization do not allow to distinguish between read-through transcripts and those due to the intrinsic promoter activity of genomic repeats. Different modifications of the 5′ rapid amplification of cDNA ends (RACE) technique allow one to precisely locate transcription start sites ([@b16]), but cannot be used for quantitative and large-scale transcriptome screenings. We aimed to develop a transcriptome-wide strategy that would make it possible to detect intrinsic promoter activity of repetitive elements. To this end, we tried to combine the advantages of 5′-RACE and nucleic acid hybridization techniques.

Here, we describe an approach termed GREM (Genomic Repeat Expression Monitor), which is based on hybridization of total pools of cDNA 5′ terminal parts to genome-wide pools of repetitive elements flanking DNA, followed by selective PCR amplification of the resulting hybrid cDNA--genome duplexes. A library of cDNA/genomic DNA hybrid molecules obtained in such a way can be used as a set of tags for individual transcriptionally active repetitive elements. The method is both quantitative and qualitative, as the number of such tags is proportional to the content of mRNA driven from the corresponding promoter active repetitive element.

We applied GREM for the genome-wide recovery of promoter active human-specific endogenous retroviruses. HERV-K (HML-2) is the only family of endogenous retroviruses known to contain human-specific members ([@b17],[@b18]). This group, whose members not only retained their transcriptional activity ([@b19]), but also probably still possess some infectious potential ([@b20],[@b21]), is thought to be among the most biologically active retroviral families of the human genome ([@b22]--[@b24]). A major part of endogenous retroviruses have undergone homologous recombination between their LTR sequences, and this family is now represented mostly by solitary LTRs ([@b25],[@b26]). Human-specific HERV-K (HML-2) LTRs share a significant sequence identity and form a well-defined cluster (named the HS family) on a phylogenetic tree ([@b17],[@b18]). The HS family is characterized by diagnostic nucleotide substitutions within the consensus sequence of HS LTRs ([@b17]). The HS family contains 156 mostly (∼86%) human-specific LTR sequences. The HS family members are represented by parts of full-sized HERV-K (HML-2) proviruses (11.5% of individual HS representatives), truncated proviruses (5.2%) or solitary LTRs (83.3%). We describe here the results of the first genome-wide identification of those LTRs serving as *in vivo* human-specific promoters in germ-line tissue and report the first comprehensive genomic map of transcriptionally active HS LTRs.

MATERIALS AND METHODS
=====================

DNA sequence analysis
---------------------

The human-specific HERV-K LTR group (HS) consensus sequence was taken from our previous work ([@b17]). LTR flanking regions were investigated with the RepeatMasker program (<http://ftp.genome.washington.edu/cgi-bin/RepeatMasker>; A. F. A. Smit and P. Green, unpublished data). Homology searches against GenBank were done using the BLAST web server at NCBI (<http://www.ncbi.nlm.nih.gov/BLAST>) ([@b27]). To determine genomic locations of LTR flanking regions, the UCSC genome browser and BLAT searches (<http://genome.ucsc.edu/cgi-bin/hgBLAT>) were used.

Oligonucleotides
----------------

Oligonucleotides were synthesized using an ASM-102U DNA synthesizer (Biosan, Novosibirsk, Russia). Their structures can be found in Table 3 of Supplementary Data.

Tissue sampling
---------------

Testicular parenchyma was sampled from a surgical specimen under non-neoplastic conditions. Representative samples were divided into two parts, one of which was immediately frozen in liquid nitrogen and the other was formalin-fixed and paraffin-embedded for histological analysis.

RNA isolation and cDNA synthesis
--------------------------------

Total RNA was isolated from frozen samples pulverized in liquid nitrogen using an RNeasy Mini RNA purification kit (Qiagen). All RNA samples were further treated with DNase I to remove residual DNA. Full-length cDNA samples were obtained according to a cap-switch effect-based SMART cDNA synthesis protocol (Clontech, BD Biosciences) using an oligo(dT)-containing primer (CDS), PowerScript reverse transcriptase (Clontech, BD Biosciences) and a riboCS oligonucleotide. When PowerScript reverse transcriptase reaches the 5′ end of the mRNA, the enzyme\'s terminal transferase activity adds a few additional deoxycytidine nucleotides to the 3′ end of the cDNA. The riboCS oligonucleotide, which contains three guanine ribonucleotide residues at its 3′ end, basepairs with the deoxycytidine stretch, creating an extended template. Reverse transcriptase then switches templates and continues the replication to the end of the oligonucleotide. The resulting full-length single stranded cDNA contains 5′ terminal sequences complementary to the riboCS oligonucleotide. An Advantage 2 Polymerase mix (Clontech), CS and CDS oligonucleotides were used to synthesize the second cDNA strands and to PCR-amplify double-stranded cDNA. Prior to further hybridization in the GREM procedure, 1 µg cDNA was digested with 10 U of AluI restriction endonuclease (Fermentas) for 3 h at 37°C. This enzyme was used because the HS LTR consensus sequence lacks AluI recognition sites.

Selective amplification of genomic regions flanking HS LTRs
-----------------------------------------------------------

Selective amplification of LTR 3′ flanking regions was based on the PCR suppression effect described in detail elsewhere ([@b28]--[@b30]). Human genomic DNA (1 µg) was digested with 10 U of AluI (Fermentas) restriction endonuclease, ethanol precipitated and dissolved in 20 µl sterile water. Then, 100 pmol of annealed suppression adapters A1A2/A3 were ligated overnight to 300 ng of the digested DNA using 3 U of T4 DNA ligase (Promega) at 16°C. The ligated DNA was purified using Quiaquick purification columns (Quiagen) and eluted with 50 µl water. Of the eluted DNA 1 µl was PCR amplified with the HS LTR-specific primer LTRfor1 and adapter-specific primer A1 using the following cycling program: (i) 72°C, 1′, (ii) 95°C, 1′ and (iii) 95°C, 15″; 65°C, 15″; 72°C, 1′ for 20 cycles. The PCR products were 500-fold diluted and used as templates for nested PCR with the downstream HS LTR-specific primer LTRfor2 and adapter-specific primer A2 under the same cycling conditions, for 22 cycles. The amplified LTR flanking sequences were treated with ExoIII exonuclease (Promega) to generate 5′ protruding termini exactly as described in Refs ([@b30],[@b31]).

GREM technique
--------------

The technique includes hybridization of PCR amplified genomic sequences flanking repetitive elements (HS LTRs in our case) with cDNA, followed by selective amplification and cloning of hybrid DNA duplexes (see Figure 2). ExoIII-treated LTR flanking sequences (100 ng), obtained as described above, were mixed with 300 ng of cDNA in 4 µl of hybridization buffer (0.5 M NaCl, 50 mM HEPES, pH 8.3, 0.2 mM EDTA), overlaid with mineral oil, denatured at 95°C for 5 min and hybridized at 68°C for 14 h. The final mixture was diluted with 36 µl of dilution buffer (50 mM NaCl, 5 mM HEPES, pH 8.3, 0.2 mM EDTA), and 1 µl of the diluted hybridization mixture was PCR-amplified with 0.2 µM adapter-specific primer A2 and 0.2 µM cDNA 5′end-specific primer CS under the following conditions: (i) 72°C for 5 min to fill in the ends of DNA duplexes, (ii) 95°C for 15″, 65°C for 15″, 72°C for 1′30″, 8 cycles. The PCR products were 500-fold diluted and reamplified by nested PCR for 20 cycles (95°C, 15″, 65°C, 15″, 72°C, 1′30″) with 0.2 µM nested adapter-specific primer A4 and 0.2 µM HS LTR 3′end-specific primer LTRfor3. The final PCR products were cloned in *Escherichia coli* using a pGEM-T vector system (Promega) and sequenced by the dye termination method using an Applied Biosystems 373 automatic DNA sequencer.

RT--PCR
-------

All RT--PCR experiments described in this section were reproduced at least three times using independent cDNA preparations. For RT--PCR control of LTR transcriptional status, we used pairs of primers, one of which was specific to the 3′ terminal part of a particular HS LTR (for sequences see Table 4 of Supplementary Material), and the other specific to a unique sequence within the corresponding genomic LTR 3′ flanking region. Prior to the RT--PCR analysis, the priming efficiency of the primers was pre-examined by genomic PCRs at temperatures varying depending on the primer combination used. These PCRs were done for 19, 22, 25 and 28 cycles, with 40 ng of the human genomic DNA template isolated from testicular parenchyma. The RT--PCR was done with cDNA samples of the same tissue, an equivalent of 20 ng total RNA being used as template in each PCR reaction performed in a final volume of 40 µl. Aliquots (5 µl) of the reaction mixture after 21, 24, 27, 30, 33, 36 and 39 cycles of the amplification were analyzed by electrophoresis in 1.5% agarose gels. In all cases, the transcriptional status was determined from the number of PCR cycles needed to detect a PCR product of the expected length and the PCR product concentration measured using a Photomat system and the Gel Pro Analyzer software.

RESULTS
=======

GREM approach features
----------------------

We have developed GREM (Genomic Repeat Expression Monitor), a transcriptome-wide approach that makes it possible to focus on the repetitive elements\' own promoter activity and to eliminate the background of read-through sequences. The resulting library of GREM clones can be used as a set of tags for individual transcriptionally active repetitive elements. This approach combines the advantages of both 5′ RACE and nucleic acid hybridization and uses the fact that REs acting as promoters initiate the transcription from within themselves, and the corresponding transcripts contain RE sequences at their 5′ termini. This is true for retroviral LTRs, LINEs and SINEs ([@b32]--[@b34]). With this in mind, we tried to specifically isolate the transcripts containing RE sequences at their 5′ termini. We showed that the number of individual tags in the library was proportional to the content of mRNA driven by the corresponding promoter active repetitive element. We used GREM to study whole genome patterns of transcripts produced by the HS LTR family members.

Transcription of proviral LTRs may result in two types of products: RNA of viral genes (if driven from the 5′ LTR, see [Figure 1](#fig1){ref-type="fig"}), or RNA of unique non-viral sequences that flank the proviral insertions at the 3′ end, provided that the 3′ LTR has a promoter capacity.

The GREM technique outlined in [Figure 2](#fig2){ref-type="fig"} consists of three major stages: (i) synthesis of full length cDNA libraries whose clones include specific oligonucleotide adapters exactly tagging the cDNA 5′ ends, (ii) selective PCR amplification of genomic repeat-flanking regions and (iii) hybridization of the genomic repeat-flanking regions to the cDNA with a subsequent PCR amplification of the genome-cDNA heteroduplexes.

The first stage of GREM is aimed at the amplification of full-length cDNAs tagged at the 5′ ends with a specific adapter oligonucleotide (CS in our case). The tagging is achieved owing to the 'cap-switch' effect in the process of cDNA synthesis. Having reached the 5′ end of the mRNA template, oligo(dT)-primed reverse transcriptase adds a few additional deoxycytidine nucleotides to the 3′ end of the cDNA. An oligonucleotide with an oligo--ribo(G) sequence at its 3′ end hybridizes to the deoxycytidine stretch to form a primer which allows reverse transcriptase to switch templates and to continue replicating to the end of the oligonucleotide. This technique allows one to precisely tag the cDNA 5′ ends that correspond to transcription start sites ([Figure 2](#fig2){ref-type="fig"}). Prior to the hybridization at stage (iii), the cDNA was digested with AluI restriction endonuclease to get shorter fragments and to avoid further background amplification of hybrids with read-through transcripts driven in the sense orientation with respect to the LTR direction ([Figure 2](#fig2){ref-type="fig"}, stage 1, step 'AluI digestion'). AluI was chosen because the HS LTR consensus sequence lacks restriction sites of this frequent-cutter endonuclease. The treatment of cDNA with AluI ([Figure 2](#fig2){ref-type="fig"}) suppresses the yield of sense read-through LTR containing products at the following stage (see below).

At the second stage, we selectively PCR amplified genomic regions flanking the 3′ termini of HS LTRs. The cDNA hybridization with the amplicon obtained was used to select the cDNA molecules that contain HS LTRs at their 5′ termini. The amplification of genomic flanking regions is a critical step ensuring the specificity of the whole procedure. Nested PCRs result in selective amplification of all target RE-flanking sequences, whereas cDNA amplification would not provide similar selectivity, as the exact locations of transcription start sites within RE sequences may vary for different individual REs ([@b7],[@b35],[@b36]) and, therefore, the design of suitable primers for PCR would be problematic.

To amplify genomic LTR flanking regions, we digested human genomic DNA with AluI restriction endonuclease, ligated the fragments obtained to a 45 nt long GC-rich synthetic linker oligonucleotide (A1A2) and performed a series of nested PCR amplifications using HS LTR specific and adapter-specific primers. As mentioned before, the HS LTR consensus sequence lacks AluI restriction sites, whereas this endonuclease normally produces DNA fragments too short to be subject to PCR fragment size selection ([@b37]). As shown previously ([@b28]--[@b30]), the use of GC-rich linkers minimizes background PCR amplification and results in almost 100% selective amplification of the expected fraction of the genome. The amplified LTR flanking sequences were treated with ExoIII exonuclease to generate 5′ protruding termini required at stage (iii) of GREM and to avoid any background cross-hybridization between LTR-containing sequences. We have recently demonstrated ([@b30],[@b31]) that ExoIII may be used to remove adapter sequences from hybridizing mixtures. Under the conditions used, ExoIII removes nucleotides slowly enough (∼5 nt/min) to more or less precisely excise ∼30 HS LTR 3′ terminal nucleotides from the amplicons. At the last step, the digested cDNA was hybridized to the LTR 3′ flanking genomic fragments. To selectively amplify the heteroduplexes containing genomic LTR flanking regions and cDNA 5′ terminal fragments generated due to LTR promoter activity, we used PCR with the CS primer against 5′ cDNA tags and A2 primer specific to the adapters ligated to the genomic DNA. This PCR step was followed by an additional nested PCR with primers A4 and LTRfor3 to increase the specificity of amplification ([Figure 2](#fig2){ref-type="fig"}).

As a result, only heteroduplexes, but not duplexes of cDNA not relevant to LTR expression or containing read-through LTRs, were amplified. As mentioned above, a potential background of transcripts containing LTRs read-through in the sense direction was supposed to be negligible. A careful inspection of human transcribed sequence databases revealed in total 38 transcripts containing read-through HS LTRs, among them only 4 LTRs in the sense orientation. An '*in silico*' simulation of AluI digestion suggested a complete removal of all such transcripts from GREM libraries.

The finally obtained amplified heteroduplexes, referred to as Expressed LTR Tags (ELTs), were further cloned and sequenced. Every particular ELT contained a 3′ HS LTR terminal portion, a fragment of the 3′ flanking genomic DNA and an adapter sequence (A4).

Detection of HS LTR promoter activity by the GREM technique
-----------------------------------------------------------

We used GREM to study the HERV-K (HML-2) LTRs promoter activity in normal testicular parenchyma. Of 500 sequenced ELT clones, 395 ELTs were selected after removal of rearranged plasmid and low-quality sequences. An ELT analysis allowed us to unambiguously map corresponding expressed solitary and 3′ proviral LTRs. A total of 54 elements were found to be promoter active in testis. However, unambiguous mapping was impossible in the case of 5′ proviral LTRs because the adjoining proviral sequences were repetitive and very similar ([Figure 1](#fig1){ref-type="fig"}). The results of the ELT analysis, presented as the first genome-wide map of promoter active HS LTRs, are shown in [Table 1](#tbl1){ref-type="table"}. For five randomly chosen individual solitary LTRs found to be promoter active according to GREM data, we precisely mapped transcription initiation sites using the 5′ RACE approach ([@b7]). In all cases, the transcription was driven from the same non-canonical promoter located on the border of the R and U5 regions within the HS LTR consensus sequence.

Linear correlation of LTR transcription levels with the corresponding ELT proportions in the GREM libraries
-----------------------------------------------------------------------------------------------------------

We further addressed the question of whether there is a correlation between an LTR directed transcript level, measured by RT--PCR, and the frequency of the corresponding ELT occurrence in the GREM libraries. The RT--PCR amplification was done with a primer specific to an LTR 3′ terminal region and directed towards the LTR 3′ end used in pair with one of the unique primers designed against genomic loci located at a distance of 70--300 bp from the LTR 3′ end. First strand cDNAs obtained for testicular parenchyma were used as templates. The transcript levels were measured relative to the housekeeping beta-actin gene transcript level. For a sampling of 20 HS LTRs, the frequencies of ELT occurrence linearly correlated with measured by RT--PCR levels of transcripts directed by the corresponding individual LTRs ([Table 2](#tbl2){ref-type="table"}) with a correlation coefficient value of 0.91. Such a correlation suggests that the GREM approach is adequate for both qualitative identification and quantitative characterization of LTRs displaying promoter activity.

DISCUSSION
==========

Now it is clear that not only protein coding transcripts are essential for normal functioning of eukaryotic cell ([@b38],[@b39]). Apart from structural and catalytic RNAs that take part in splicing, translation, X chromosome inactivation and protein sorting, a huge number of evolutionary conserved non-coding RNAs are thought to be involved in gene expression regulation in a wide variety of species ([@b40]). REs, which were constantly being 'domesticated' by host genomes in evolution, might provide regulatory modules for the expression of such RNAs. They could also cooperate with pre-existing gene structures to form new splice sites or regulatory RNAs ([@b4]). A comprehensive analysis of such an RE-controlled diversity of RNAs will be undoubtedly required for further functional characterization of the human genome. Focusing on human-specific REs would allow to identify candidate regulators that emerged in human genome evolution and contributed to the human--chimpanzee divergence ([@b41]).

HS LTR expression
-----------------

A detailed functional analysis of individual promoter active LTRs revealed in this study is under way in our laboratory. Here we only mention that not only 5′ proviral LTRs, whose transcriptional activity is absolutely required for viral gene expression, but also 3′ proviral and solitary LTRs could serve as active promoters in human testicular parenchyma *in vivo*. As seen from [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}, some of the latter elements were transcribed at strikingly high levels, as for example solitary LTRs 5, 22 and 37, and 3′ proviral LTR 9. Interestingly, the transcriptional activity of even almost sequence identical promoter competent HS elements greatly differed ranging from ∼0.004 to ∼3% of the beta-actin transcript level (almost a 1000-fold range according to RT--PCR and in good agreement with the GREM data). Therefore, the LTR status (solitary, 3′ or 5′ proviral) *per se* cannot explain why the transcript levels are so different for different individual LTRs, and other hypotheses, probably based on chromatin structure-dependent transcriptional regulation, should be considered to clarify the situation.

GREM technique, rationale and potentials
----------------------------------------

In this article we describe the first application of a new technique aimed at genome- and transcriptome-wide detection of promoter active repetitive elements. As demonstrated here by the example of HS LTRs, GREM allows one to correctly identify RE-driven transcripts and, therefore, promoter active REs. Moreover, the technique can be also used to quantitatively estimate the contribution of individual repetitive elements to the transcriptome. The GREM protocol contains a stage of DNA hybridization and several PCR amplification steps, and therefore we tried to minimize possible bias effects. In particular, the well-known PCR fragment size selection effect was practically excluded by shortening DNA fragments to 100--300 bp with frequent-cutter AluI enzyme. Another possible problem of PCR selection in favor of GC-rich sequences was solved using highly processive DNA polymerases (Clontech Advantage Polymerase Mix). Finally, the time--temperature conditions of hybridization in this study were chosen to provide reassociation of ∼99% hybridizing molecules \[for reassociation kinetics formulas, see ([@b42])\]. The theoretical considerations above were supported by a linear correlation of GREM tag frequencies with RT--PCR-measured contents of corresponding transcripts. Thus, being an adequate technique for large-scale transcriptome analyses, GREM provides a unique advantage of the selection of RE-promoted transcripts free of sense and antisense read-through background. This was in addition confirmed by an '*in silico*' GREM library construction, where the final pool of GREM tags lacked all 38 known HS LTR read-through cDNAs (see above). Theoretically, for genomic repeats other than HS LTRs, a small number of read-through transcripts in the sense orientation, initiated at 100--300 bp upstream of REs (located closer than the closest frequent-cutter endonuclease restriction site), may appear as false-positive clones. However, a simple RT--PCR test with a primer specific to a genomic sequence located immediately upstream of the repetitive element would definitely answer the question whether the transcription is initiated from within the RE ([Table 3](#tbl3){ref-type="table"}).

Of course, GREM is not free of limitations. First, it cannot be applied to the analysis of non-polyadenylated transcripts, which form a significant portion of the human transcriptome ([@b43]). Therefore, the use of GREM is restricted to RNA polymerase II-transcribed repeats. Also, successful application of this method partly depends on the sequence divergence among repetitive elements under comparison. If this divergence is high, oligonucleotide primers designed from the group consensus sequence may fail to prime PCR with the group members diverged too far from the consensus. However, to improve the priming, degenerated nucleotide primers may be utilized. Alternatively, large groups of repeats could be subdivided into more sequence similar subgroups. Finally, although the stage of ExoIII digestion may seem to complicate the method, this is a common procedure making GREM a one-tube approach. The GREM technique can be similarly applied to any other group of human or non-human repeats.

It should be mentioned here that the GREM protocol could be markedly simplified under the following conditions: (i) if the transcription initiation point within an RE under study is already unambiguously mapped, thus making it possible to correctly design PCR primers and (ii) if the 3′-terminal part of a repetitive element, that remains in the repeat-driven transcript, is long enough to design PCR primers for exclusive amplification of the sequences containing REs of interest. In this case, the same pool of cDNA-derived tags can be obtained by (i) amplifying total double-stranded cDNA; (ii) digesting it by AluI; (iii) ligating a suppression adapter (such as A1A2) and (iv) performing a two-stage amplification, first with CS and A1 primers, and then (nested stage) with 'LTRfor2-like' and A2 primers. There would be no need for complex additional procedures such as isolation of genomic REs\' flanks, their hybridization to cDNA-derived products and selective amplification of the product. Actually, it is very difficult to find an example of an RE family with a known uniform transcriptional start site, even among human REs that are thought to be better investigated than the others. Computational approaches are of little help, since their predictions are probabilistic. Moreover, multiple alternative transcriptional start sites may exist, as shown previously, for example, for L1 retrotransposons ([@b35],[@b36]) and for HERV-K (HML-2) endogenous retroviruses studied here ([@b7]). In principle, the very 3′-terminal sequence of REs might be used for primer design in order to amplify all alternative transcripts, but in many cases this sequence will be insufficient to give a proper primer set for selective amplification of RE-containing cDNAs. For example, a few hundred base pairs long HS LTR 3′-terminal sequence resides also within so called SVA retrotransposons that are far more abundant in human DNA than HS LTRs ([@b17],[@b44]).

Concluding remarks
------------------

Here, we described the technique termed GREM developed for genome-wide isolation and quantitative analysis of any kind of promoter active repetitive elements. This technique enabled us to make the first attempt to identify genomic repeat-associated promoter activity in a genome-wide study. We were able to both build the first genome-wide map of promoter active human-specific endogenous retroviruses and individual solitary LTRs, and we were able to quantitatively characterize promoter activities of particular elements. A detailed GREM data analysis and GREM profile comparisons for different human tissues will be a further extension of this work.
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![Schematic representation of solitary (left) and proviral (right) LTRs expression. The transcription driven from 5′ proviral LTRs results in mRNAs of viral genes, whereas the expression of either solitary or 3′ proviral LTRs results in the transcription of host genomic sequences, flanking the 3′ ends of the retroelements.](gkl335f1){#fig1}

![Schematic representation of the GREM technique (for details, see text). The procedure includes three major stages: (Stage 1) genome-wide amplification of the genomic DNA flanking the 3′ ends of target repetitive elements (here, HS LTRs). Treatment of the resulting amplicon with ExoIII generates 5′ protruding ends to be used at the third stage. (Stage 2) A double-stranded oligo d(T)-primed cDNA library is synthesized for tissues where expression of repetitive elements is to be studied. At this stage cDNAs are tagged by a linker oligonucleotide (CS) at the RNA transcription start sites using the 'cap-switch' effect. cDNAs are then digested with AluI restriction endonuclease that has no recognition sites within HS LTRs. This step precludes amplification of LTR sequences read-through in the sense orientation. (Stage 3) Finally, the genomic DNA amplicon (Stage 1) is hybridized to the 5′ tagged cDNAs (Stage 2). The protruding DNA ends are filled in with DNA polymerase, and the hybrids obtained (ELTs) are nested PCR amplified with primers specific to the flanking genomic DNA adapter and cDNA 5′ terminal tag sequence, respectively.](gkl335f2){#fig2}

###### 

Genome-wide map of promoter active HS LTRs with relative contents of expressed LTR tags (ELTs) for human testicular parenchyma

  LTR ID             GenBank^a^   Genomic location   ELT content (%)^b^   Status of LTR   Human specificity (+/−)
  ------------------ ------------ ------------------ -------------------- --------------- -------------------------
  1                  AL359965     1p32.3             0.25                 Solitary        \+
  2                  AL356379     1p34.2             0.50                 Solitary        −
  3                  AL355480     1p34.1             0.50                 Solitary        \+
  4                  AL139421     1p22.1             0.50                 Solitary        \+
  5                  AL135927     1q22               5.57                 Solitary        \+
  6                  AL353807     1q23.1             0.25                 3′ proviral     \+
  7                  AC011811     2q37.1             0.50                 Solitary        \+
  8                  AC074019     2q36.3             0.50                 Solitary        \+
  9                  AC069420     3q27.2             32.66                3′ proviral     \+
  10                 AC025548     3p21.31            0.25                 Solitary        \+
  11                 AC024626     4                  0.25                 Solitary        \+
  12                 AC118278     4p16.3             1.77                 Solitary        \+
  13                 AC110373     4q26               1.27                 Solitary        −
  14                 AC010267     5q23.1             0.25                 Solitary        \+
  15                 AC116309     5p13.3             2.53                 3′ proviral     \+
  16                 AC026424     5q13.3             0.25                 Solitary        \+
  17                 AC008648     5q35.1             0.25                 Solitary        \+
  18                 AC016577     5q33.3             1.52                 3′ proviral     \+
  19                 AL139090     6q15               1.01                 Solitary        \+
  20                 AL009179     6p22.1             0.50                 Solitary        −
  21                 AC026010     6q23.2             0.76                 Solitary        \+
  22                 AL451165     6p21.31            15.19                Solitary        \+
  23                 AL138889     6p21.31            0.25                 Solitary        \+
  24                 AL590543     6q25.1             0.25                 Solitary        −
  25                 AL589643     6q21               0.25                 Solitary        \+
  26                 AC023201     6q25.1             0.25                 Solitary        \+
  27                 AL353588     6p21.1             0.25                 Solitary        −
  28                 AC069335     7q34               1.01                 Solitary        −
  29                 AC021973     8q24.3             0.25                 3′ proviral     \+
  30                 AC120036     8q11.21            0.50                 Solitary        \+
  31                 AF235103     8q24.3             0.50                 Solitary        −
  32                 AC015640     9p22.2             0.50                 Solitary        \+
  33                 AL162412     9q21.12            0.50                 Solitary        \+
  34                 AL353766     9q31.2             0.50                 Solitary        \+
  35                 AC068707     10q11.21           1.27                 Solitary        −
  36                 AL392107     10q24.2            0.25                 3′ proviral     \+
  37                 BC001407     10q21.3            2.79                 Solitary        \+
  38                 AP002754     11q12.2            0.25                 Solitary        −
  39                 AP002513     11q13.4            1.01                 Solitary        \+
  40                 AP002793     11q12.13           0.50                 Solitary        −
  41                 AP003385     11q13.2            0.25                 Solitary        \+
  42                 AC002350     12q24.11           0.25                 3′ provirus     \+
  43                 U47924       12p13.31           0.76                 Solitary        \+
  44                 AL135901     13q14.2            0.25                 Solitary        −
  45                 AC055861     15q26.3            0.50                 Solitary        \+
  46                 AC026817     15q22.2            0.50                 Solitary        \+
  47                 AC068213     15q22.31           0.76                 Solitary        \+
  48                 AC018768     16p13.2            0.25                 Solitary        \+
  49                 AC012175     16p13.3            0.25                 Solitary        \+
  50                 AC012146     17p13.2            1.52                 Solitary        \+
  51                 AC008996     19q12              0.25                 3′ proviral     \+
  52                 AL109748     21q11.2            0.50                 Solitary        \+
  53                 AC007326     22q11.21           0.25                 3′ proviral     \+
  54                 AL109653     Xq27.3             0.25                 Solitary        \+
  5′ proviral LTRs                                   14.94                5′ proviral     

^a^GenBank accession number corresponding to the LTR; not applicable to 5′ proviral LTRs line.

^b^The relative ELT content calculated as a ratio of the number of tags for each individual HS LTR to the total number (395) of all ELTs in the sequenced library.

###### 

Relative LTR transcript levels and frequency of occurrence of the corresponding ELTs for testicular parenchyma

  LTR ID             Transcript level^a^ (percentage of the beta-actin gene transcript level)   ELT frequency (%)
  ------------------ -------------------------------------------------------------------------- -------------------
  4                  0.26 ± 0.09                                                                0.50
  9                  2.9 ± 0.2                                                                  32.66
  12                 0.16 ± 0.05                                                                1.77
  16                 0.17 ± 0.03                                                                0.25
  17                 0.02 ± 0.005                                                               0.25
  18                 0.24 ± 0.03                                                                1.52
  22                 1.4 ± 0.4                                                                  15.19
  24                 0.032 ± 0.013                                                              0.25
  27                 0.13 ± 0.04                                                                0.25
  37                 0.35 ± 0.06                                                                2.79
  38                 0.16 ± 0.04                                                                0.25
  43                 0.059 ± 0.014                                                              0.76
  47                 0.12 ± 0.02                                                                0.76
  55                 0.004 ± 0.001                                                              0
  56                 0                                                                          0
  57                 0                                                                          0
  58                 0.24 ± 0.03                                                                3.61
  59                 0.013 ± 0.004                                                              0
  60                 0.01 ± 0.003                                                               0
  5′ proviral LTRs   1.08 ± 0.09                                                                14.94

^a^Relative transcript levels measured by RT--PCR.

###### 

Genomic primer sets used for PCR amplification

  Name                                                                    Sequence (5′--3′)                               Accession^a^
  ----------------------------------------------------------------------- ----------------------------------------------- --------------
  Oligonucleotides used for GREM procedure                                                                                
      (1) LTR specific primers                                                                                            
          LTRfor1                                                         gtcttgtgaccctgacacatcc                          ---
          LTRfor2                                                         cctccatatgctgaacgctg                            ---
          LTRfor3                                                         ggggcaacccacccctac                              ---
      (2) Suppression adapter oligonucleotides                                                                            
          A1A2                                                            gtaatacgactcactatagggcagtcgacgcgtgcccggtccgac   ---
          A3                                                              gtcggaccgggc                                    ---
          A1                                                              gtaatacgactcactatagggc                          ---
          A2                                                              agtcgacgcgtgcccggtccgac                         ---
          A4                                                              tcgacgcgtgcccggtccgacct                         
      (3) Oligonucleotides used for cap-switch based cDNA amplification                                                   
          CDS                                                             aagcagtggtatcaacgcagagtac(t)~30~                ---
          riboCS                                                          taacaacgcagagtacgc~r~g~r~g~r~g                  ---
          CS                                                              taacaacgcagagtacgcgg                            ---
  Primers used for RT--PCR experiments                                                                                    
      (1) LTR specific primers                                                                                            
          LTRfor1                                                         gtcttgtgaccctgacacatcc                          ---
          LTRfor2                                                         cctccatatgctgaacgctg                            ---
          LTRfor3                                                         ggggcaacccacccctac                              ---
      (2) Unique genomic primers specific for LTR 3′ flanking regions                                                     
          gLTR55                                                          taagtggatataattactaagtccagg                     AC068381
          gLTR38                                                          ccaacatctgtctcttccctg                           AP002754
          gLTR22                                                          gaccatttgcatggacaaatc                           AL451165
          gLTR9                                                           ccatcccttccatgccttag                            AC069420
          gLTR56                                                          agctttgtggattgtaatttgg                          AC072054
          gLTR4                                                           ctcagtaaagatgaaggtatgacaag                      AL139421
          gLTR57                                                          gaggcagaggttgcagtgagcc                          AC002400
          gLTR16                                                          ataaaggagaaatcttccatgaag                        AC026424
          gLTR17                                                          tgtgacggtataatggcctct                           AC008648
          gLTR58                                                          ggttatgaataaagttccctcgg                         AC027750
          gLTR59                                                          agaatagagcgaacagacacag                          AL352982
          gLTR24                                                          aggttattgatacattgcatcgac                        AC023201
          gLTR12                                                          caataacagtcattctcactggag                        AC118278
          gLTR27                                                          gagttgggatgtggtcttagg                           AL353588
          gLTR60                                                          ctcatgctaaactgtctgattatgc                       AC105049
          gLTR37                                                          ttgtgcaaactgtctacagcca                          BC001407
          gLTR18                                                          aacatacaggttgaggccagg                           AC016577
          gLTR47                                                          ttgtagctgaccaacagcctgc                          AC068213
          gLTR43                                                          ttaggccagggtctcactgag                           U47924
      (3) HERV-K (HML-2) proviral gene gag specific primer                                                                
          Gag rev                                                         aatggcccaatcattccata                            ---

^a^GenBank accession numbers of corresponding LTRs from non-redundant and high throughout genome sequence databases.
